MQS Management’s AbbVie ABBV Stock Holding History

MQS Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$390K	Sell	1,793 -1,150	-39%	-$255K	0.26%	150
2025 Q4	$672K	Buy	+2,943	New	+$670K	0.4%	60
2023 Q3	–	Sell	-2,693	Closed	-$363K	–	409
2023 Q2	$363K	Buy	+2,693	New	+$395K	0.25%	159
2022 Q3	–	Sell	-3,015	Closed	-$462K	–	392
2022 Q2	$462K	Buy	+3,015	New	+$461K	0.32%	116

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MQS Management's ABBV Position: Q1 2026 in Review

MQS Management reduced its AbbVie (ABBV) stake by 39% in Q1 2026, selling an estimated $255K and leaving 1,793 shares worth $390K. The position accounts for 0.26% of the portfolio, ranked #150.

MQS Management first reported a position in ABBV in Q2 2022 and has held it in 4 quarters since. The position peaked at $672K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

MQS Management held 1,793 shares of AbbVie worth $390K as of Q1 2026.
MQS Management sold 1,150 AbbVie shares in Q1 2026, an estimated $255K.
AbbVie made up 0.26% of MQS Management's portfolio in Q1 2026, its #150 holding.
MQS Management first reported a position in AbbVie in Q2 2022 and has held it in 4 quarters since.
MQS Management's AbbVie position peaked at $672K in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MQS Management's 13F filing for Q1 2026, filed 23 Apr 2026.